Foghorn Therapeutics Inc. - stock earnings
FHTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -24.1 million USD | 5.8 million USD |
| 2023Q3 | -14.3 million USD | 17.5 million USD |
| 2023Q2 | -29.5 million USD | 5.6 million USD |
| 2023Q1 | -30.5 million USD | 5.3 million USD |
| 2022Q4 | -34.1 million USD | 4.2 million USD |
| 2022Q3 | -23.3 million USD | 6.6 million USD |
| 2022Q2 | -25.4 million USD | 4.5 million USD |
| 2022Q1 | -26.0 million USD | 3.9 million USD |
| 2021Q4 | 170.8 million USD | 713000 USD |
| 2021Q3 | -26.1 million USD | 41000 USD |
| 2021Q2 | -23.1 million USD | 279000 USD |
| 2021Q1 | -23.0 million USD | 286000 USD |
| 2020Q4 | -68800 USD | 251000 USD |
| 2020Q3 | -18.4 million USD | 179000 USD |
| 2020Q2 | -15.7 million USD | ? USD |
| 2020Q1 | -14.0 million USD | ? USD |
| 2019Q4 | -15.3 million USD | ? USD |
| 2019Q3 | -13.1 million USD | ? USD |
| 2019Q2 | -12.8 million USD | ? USD |
| 2019Q1 | -12.8 million USD | ? USD |
| 2018Q4 | -12.8 million USD | ? USD |
| 2018Q2 | -6.6 million USD | ? USD |
| 2018Q1 | -6.6 million USD | ? USD |
| 2017Q4 | -6.6 million USD | ? USD |
FHTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -98.4 million USD | 34.2 million USD |
| 2022 | -108.9 million USD | 19.2 million USD |
| 2021 | -103.2 million USD | 1.3 million USD |
| 2020 | -69.8 million USD | 430000 USD |
| 2019 | -51.7 million USD | ? USD |
| 2018 | -26.3 million USD | ? USD |
FHTX
Price: $5.99
52 week price:
Earnings Per Share: -2.34 USD
P/E Ratio: -2.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 18512
Market Capitalization: 306.9 million